Latest Regulatory Uncertainty News

Infinity Lithium progresses its Australian gold-copper-silver exploration with new option agreements, while facing delays and strategic shifts in its Spanish lithium project.

Yugo Metals Limited has launched a $100,000 capital raising through a new options offer, aiming to bolster working capital while navigating significant geopolitical and operational challenges in Bosnia and Herzegovina.

MIXI Australia Pty Ltd has initiated an all-cash off-market takeover bid for PointsBet Holdings Limited at $1.20 per share, a significant premium recommended unanimously by the PointsBet Board. The offer promises certainty of cash consideration amid competing bids and regulatory conditions.

MIXI Australia has lodged a bidder’s statement for an all-cash $1.20 per share takeover offer for PointsBet Holdings Limited, with the PointsBet Board unanimously recommending acceptance in the absence of a superior proposal.

G8 Education faces ASX scrutiny over its handling of sensitive information about a former employee, with the regulator questioning the company’s disclosure practices despite GEM’s insistence of compliance.

The Takeovers Panel has decided not to proceed with an application challenging Keybridge Capital’s board decisions amid Yowie Group’s takeover bid, citing prior rulings and no unacceptable circumstances.

Coda Minerals has submitted the Draft Scoping Report for its Elizabeth Creek Copper-Cobalt Project, marking a pivotal step in securing mining lease approvals in South Australia. This milestone reduces regulatory uncertainty and sets a clear path toward project development.

Aguia Resources has locked in $2.687 million in loan commitments, including a $500,000 stake from its Executive Chairman, to fund ongoing mine development and exploration in Colombia. The loans feature convertible terms and options issuance, pending shareholder and ASX approvals.

Neurizon Therapeutics has received positive feedback from the FDA on its plan to resolve the clinical hold on its ALS drug candidate NUZ-001, with key preclinical studies completed ahead of schedule. The company aims to resume clinical trials in late 2025.

Nova Minerals has filed a Form F-1 registration statement with the U.S. SEC for a secondary offering of its American Depositary Shares, aiming to raise capital for advancing its Estelle Project in Alaska.

Arrow Minerals has completed key scoping studies for its Niagara Bauxite and Simandou North Iron projects but has halted operations in Guinea due to unclear exploration permit status.

Omni Bridgeway confirms the US Budget Bill signed on 4 July 2025 excludes the proposed Legal Finance tax, a move welcomed by the company amid broad political support.